-The Indian Express Responding to specific queries on the issue, Bhupendra Singh, NPPA chairman, told The Indian Express that “examination of hospital records is in process”. AFTER the National Pharmaceutical Pricing Authority (NPPA) in February ordered a cap on the prices of coronary stents and directed hospitals to issue separate bills specifying their cost, the drug pricing watchdog has started receiving consumer complaints against hospitals which are allegedly hiking the prices...
More »SEARCH RESULT
Stents sold in Europe for less than Indian prices -Rema Nagarajan
-The Times of India Multinational stent companies claim that the ceiling price fixed by the National Pharmaceutical Pricing Authority (NPPA) is commercially unviable, but they are selling at far lower prices in much richer countries with smaller markets than India such as Germany, the UK, Italy and many other European countries. A look at the prices of stent brands in these countries shows that people in India have been defrauded of crores...
More »Can doctors judge best quality in medicines? -Jyotsna Singh
-The Hindu Doctors’ objections to prescribing medicines by generic names fly in the face of a recent report on substandard drugs In a surprise move on April 17, Prime Minister Narendra Modi announced that his government will soon make it mandatory for doctors to prescribe medicines by generic names. The decision was to ensure drug prices remain affordable and patients get a wider bouquet of options instead of being forced to...
More »Sponsors banned: Docs asked to raise funds for conferences -Durgesh Nandan Jha & Rema Nagarajan
-The Times of India NEW DELHI: The Indian Medical Association (IMA) has asked its state and local units to raise funds from member doctors to organise conferences and functions instead of seeking sponsorship. According to IMA office-bearers, the decision was taken at a meeting on Wednesday in view of allegations about pharmaceutical companies and the device industry shaping the content and style of medical conferences. "If doctors want to meet at a...
More »Generic medicines in a digital age -Dinesh S Thakur & Prashant Reddy T
-The Hindu We need a legal mechanism to ensure that all generics are of the same standard as the innovator product The Prime Minister’s recent announcement on making it mandatory for doctors to prescribe only the generic name, and not brand name of a drug, has led to a flutter. If enacted, the move will make it illegal for Indian doctors to write out a prescription for the trademark of the drug,...
More »